Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma

1 Jan 2021

Abstract excerpt

Hepatocellular carcinoma (HCC) is one of the most common malignancies globally and the second leading cause of cancer-related death. Low-density lipoprotein (LDL) receptor-related protein 1B (LRP1B) is one of the commonly mutated genes in HCC, but its role in HCC remains unclear. In this study, we analyzed the role of LRP1B mutation in HCC. The bioinformatics results show that LRP1B had a frequency of mutation in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34093808
DOI: 10.7150/jca.53124

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinomaPMID 34093808Read ↗

LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma.Semantic proximity Read ↗

Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.Semantic proximity Read ↗

Development and validation of a LRP1B mutation-associated prognostic model for hepatocellular carcinomaSemantic proximity Read ↗

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinomaSemantic proximity Read ↗

Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.Semantic proximity Read ↗

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics AnalysisSemantic proximity Read ↗

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics AnalysisSemantic proximity Read ↗

LRP1B in cancer: From a mutation landscape to predictive biomarkers for precision oncology.Semantic proximity Read ↗

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.Semantic proximity Read ↗

CTNNB1-mutation-related immune gene prognostic model (CMRIPM) for hepatocellular carcinoma: Development and validationSemantic proximity Read ↗

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.Semantic proximity Read ↗

A gene mutation-based risk model for prognostic prediction in liver metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.